ScienceDirect® Home Skip Main Navigation Links
You have guest access to ScienceDirect. Find out more.
 
Home
Browse
My Settings
Alerts
Help
 Quick Search
 Search tips (Opens new window)
    Clear all fields    
advertisementadvertisement
Bioorganic & Medicinal Chemistry
Volume 13, Issue 3, 1 February 2005, Pages 909-915
 
Font Size: Decrease Font Size  Increase Font Size
 Abstract - selected
Article
Purchase PDF (394 K)

 
 
 
Related Articles in ScienceDirect
View More Related Articles
 
View Record in Scopus
 
doi:10.1016/j.bmc.2004.06.047    How to Cite or Link Using DOI (Opens New Window)
Copyright © 2004 Elsevier Ltd All rights reserved.

A new strategy for glycoprotein synthesis: ligation of synthetic glycopeptides with truncated proteins expressed in E. coli as TEV protease cleavable fusion protein

Thomas J. Tolbert, Dirk Franke and Chi-Huey WongCorresponding Author Contact Information, E-mail The Corresponding Author

Department of Chemistry and The Skaggs Institute for Chemical Biology, The Scripps Research Institute, 10550 North Torrey Pines Road, BCC 483A, La Jolla, CA 92037, USA

Received 22 June 2004; 
accepted 22 June 2004. 
Available online 10 November 2004.

Purchase the full-text article



References and further reading may be available for this article. To view references and further reading you must purchase this article.

Abstract

We report here the use of TEV protease cleavable fusion proteins to produce glycosylated bioactive peptides and proteins. Bacterial expression was utilized to produce two fusion proteins, GPRT-C37-H6 and His-tagged interleukin-2 (amino acids 6–133), which when cleaved by the tobacco etch virus NIa protease (TEV protease) to generate HIV entry inhibitor peptide C37-H6 and a truncated version of the cytokine interleukin-2, both containing N-terminal cysteines. The N-terminal cysteine containing C37-H6 and truncated interleukin-2 were then joined to a synthetic glycopeptide thioester utilizing native chemical ligation under nondenaturing and denaturing conditions, respectively. The ligations of the glycopeptide to the C37-H6 peptide and the truncated interleukin-2 protein both proceeded in high yield, though the size, and physical properties of the two polypeptides differ greatly.

Graphical abstract


Article Outline

1. Introduction
2. Results and discussion
3. Conclusion
4. Experimental
4.1. General
4.2. Cloning of GPRT-C37-H6
4.3. Production and purification of GPRT-C37-H6
4.4. Cloning of His-tagged interleukin-2 (6–133)
4.5. Production and purification of His-tagged interleukin-2 (6–133)
4.6. TEV protease cleavage of GPRT-37-H6
4.7. TEV protease cleavage of His-tagged interleukin-2 (6–133)
4.8. Synthesis of H-Asn(GlcNAc)-Gly-Gly-thioester
4.8.1. Synthesis of 1 (Boc-Asn(GlcNAc)-Gly-Gly-OH)
4.8.2. Synthesis of 2 (H-Asn(GlcNAc)-Gly-Gly-thioester)
4.9. Ligation of H-Asn(GlcNAc)-Gly-Gly-thioester to C37-H6
4.10. Ligation of H-Asn(GlcNAc)-Gly-Gly-thioester to interleukin-2 (6–133)
Acknowledgements
Supplementary data
References








Bioorganic & Medicinal Chemistry
Volume 13, Issue 3, 1 February 2005, Pages 909-915
 
Home
Browse
My Settings
Alerts
Help
Elsevier.com (Opens new window)
About ScienceDirect  |  Contact Us  |  Information for Advertisers  |  Terms & Conditions  |  Privacy Policy
Copyright © 2008 Elsevier B.V. All rights reserved. ScienceDirect® is a registered trademark of Elsevier B.V.